Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rilan Bai

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|January 18, 2020
Challenges of evaluating immunotherapy efficacy in solid tumorsRilan Bai, Wenqian Li, Nawen Du, et al.
Chinese Medical Journal|June 27, 2023
Epidermal growth factor receptor compound and concomitant mutations: advances in precision treatment strategiesWenqian Li, Rilan Bai, Hanfei Guo, et al.
Biomarker Research|September 1, 2020
Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitorsRilan Bai, Zheng Lv, Dongsheng Xu, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|September 9, 2024
Immune status and combined immunotherapy progression in Kirsten rat sarcoma viral oncogene homolog (KRAS)-mutant tumorsDongsheng He, Rilan Bai, Naifei Chen, et al.
Journal of Cancer Research and Clinical Oncology|October 26, 2021
Therapeutic exploration of uncommon EGFR exon 20 insertion mutations in advanced non-small cell lung cancer: breaking through brambles and thornsRilan Bai, Xiao Chen, Wei Song, et al.
Molecular Carcinogenesis|September 6, 2024
ADAR1 Promotes Invasion and Migration and Inhibits Ferroptosis via the FAK/AKT Pathway in Colorectal CancerDongsheng He, Chao Niu, Rilan Bai, et al.
Frontiers in Oncology|November 9, 2020
Neoadjuvant and Adjuvant Immunotherapy: Opening New Horizons for Patients With Early-Stage Non-small Cell Lung CancerRilan Bai, Lingyu Li, Xiao Chen, et al.
Frontiers in Oncology|August 15, 2020
Novel Frontiers of Treatment for Advanced Gastric or Gastroesophageal Junction Cancer (GC/GEJC): Will Immunotherapy Be a Future Direction?Rilan Bai, Naifei Chen, Tingting Liang, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|September 29, 2021
Advances in novel molecular typing and precise treatment strategies for small cell lung cancerRilan Bai, Lingyu Li, Xiao Chen, et al.
Thoracic Cancer|August 17, 2022
Targeted therapy combined with immunotherapy in patients with breast infiltrating ductal carcinoma with axillary lymph node metastasis of metaplastic SCCRilan Bai, Lin Jia, Yangyang Gao, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|January 18, 2020
Challenges of evaluating immunotherapy efficacy in solid tumorsRilan Bai, Wenqian Li, Nawen Du, et al.
Chinese Medical Journal|June 27, 2023
Epidermal growth factor receptor compound and concomitant mutations: advances in precision treatment strategiesWenqian Li, Rilan Bai, Hanfei Guo, et al.
Biomarker Research|September 1, 2020
Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitorsRilan Bai, Zheng Lv, Dongsheng Xu, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|September 9, 2024
Immune status and combined immunotherapy progression in Kirsten rat sarcoma viral oncogene homolog (KRAS)-mutant tumorsDongsheng He, Rilan Bai, Naifei Chen, et al.
Journal of Cancer Research and Clinical Oncology|October 26, 2021
Therapeutic exploration of uncommon EGFR exon 20 insertion mutations in advanced non-small cell lung cancer: breaking through brambles and thornsRilan Bai, Xiao Chen, Wei Song, et al.
Molecular Carcinogenesis|September 6, 2024
ADAR1 Promotes Invasion and Migration and Inhibits Ferroptosis via the FAK/AKT Pathway in Colorectal CancerDongsheng He, Chao Niu, Rilan Bai, et al.
Frontiers in Oncology|November 9, 2020
Neoadjuvant and Adjuvant Immunotherapy: Opening New Horizons for Patients With Early-Stage Non-small Cell Lung CancerRilan Bai, Lingyu Li, Xiao Chen, et al.
Frontiers in Oncology|August 15, 2020
Novel Frontiers of Treatment for Advanced Gastric or Gastroesophageal Junction Cancer (GC/GEJC): Will Immunotherapy Be a Future Direction?Rilan Bai, Naifei Chen, Tingting Liang, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|September 29, 2021
Advances in novel molecular typing and precise treatment strategies for small cell lung cancerRilan Bai, Lingyu Li, Xiao Chen, et al.
Thoracic Cancer|August 17, 2022
Targeted therapy combined with immunotherapy in patients with breast infiltrating ductal carcinoma with axillary lymph node metastasis of metaplastic SCCRilan Bai, Lin Jia, Yangyang Gao, et al.
Pageof 3